Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that its Board of Directors has appointed Mario Alberto Accardi PhD, President and founder of ...

Candidates have been instructed that responses written in incorrect sections will not be taken into account during evaluation ...

NEET UG 2026 is expected on the first Sunday of May. Check your preparation with these high-yield Plant Physiology ...

Hours after receiving her grade, she asked the Gov. Kevin Stitt, former State schools Superintendent Ryan Walters and the OU ...

Abstract: Continuous monitoring of fluid status through bioimpedance (Bio-Z) measurement of thoracic magnitude or phase is critical in reducing the mortality of chronic heart failure (CHF) patients.

In case you've faced some hurdles solving the clue, Memorial bio, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test your ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A new Cambridge biotech company ...

Rukmini Vasanth is all over the internet due to her beauty and good performances in all of her 2025 releases. In the latest news, she is grabbing all the limelight for Kantara: Chapter 1. For the ...

From startups to giants in pharma and tools, the use of spatial biology is growing in importance in drug discovery. LatchBio, a four-year-old San Francisco builder of software and data infrastructure ...

During its more than 10-year run across both the anime and the manga, My Hero Academia has treated us to many adventures with Class 1-A, taking us all the way to season 8 on the screen. But the series ...

Kantara Chapter 1 Box Office: Will It Surpass 10th Biggest Pre-Sales? ( Photo Credit – YouTube ) Helmed by Rishab Shetty, the official synopsis of the film says, “Exploring the origins of Kaadubettu ...

Non-exclusive license for Solid Biosciences’ proprietary, next-generation myotropic capsid, AAV-SLB101, to accelerate development of KNA-155 for dysferlinopathy SEATTLE, September 23, 2025--(BUSINESS ...